Ascension St. John Hospital Hematology Oncology Fellowship
Ascension St. John Hospital Hematology and Oncology Subspecialty Fellowship Training Program is a three year combined Hematology and Oncology Program targeting qualified candidates each year.
The training program comprises of 14 months of in-hospital clinical rotations, 10 months of elective/clinical rotations, and 12 months of basic or clinical research experience, continuity clinics and planned didactic conferences and lectures throughout the 3-year program.
Each Hematology Oncology fellow receives support to attend one professional meeting each year such as the American Society of Hematology or American Society or Clinical Oncology.
Each fellow is nominated for professional membership in these Societies.
Daniel Lebovic, MD
Chief of Hematology/Oncology Department
Assistant Professor, Division of Hematology/Oncology, U of M
Zyad Kafri, MD, MS, FACP
Assistant Professor of Medicine, WSU
Ayad Al-Katib, MD, FACP
Director of Research Van Elslander Cancer Center
Associate Program Director
Professor of Medicine, WSU
Tarik Hadid, MD, MS, FACP
Assistant Professor of Medicine, WSU
Carrie Dul, MD
Lokesh Nagori, MD
Training is divided as follows
- Hematology - 6 months
- Oncology - 5 months
- Malignant Hematology - 1 month
- Bone Marrow Transplant - 1 month
- General Hematology/Oncology Continuity Clinic - 1/2 day weekly
- Specialty Clinic Breast - 2 months
- Specialty Clinic Hematology - 2 months
- Specialty Clinic Gastrointestinal Oncology/Genetics - 2 months
- Lab Medicine/Apheresis - 1 month
- GYN Oncology - 1 month
- Pediatric Hematology/Oncology - 1 month
- Radiation Oncology - 1 month
- Palliative Care Service - 1 month
- 12 months
The inpatient oncology and the inpatient hematology services provide consultations on patients with cancer or blood disorders who are hospitalized in Ascension St. John Hospital. In addition, these services provide care for patients admitted to the oncology or hematology inpatient services. The assigned resident and fellow are responsible for evaluating the patient’s history, clinical and laboratory findings and using these to make recommendations for further diagnostic evaluations, treatment and monitoring of response. The treatment plan should include management of the cancer and its related symptoms, taking into consideration co-existing clinical conditions. The Hematology-Oncology resident and fellow will present the data to the attending physician on the oncology service and will prepare the official written interpretation and recommendations for the referring physician. The resident and fellow will also continue to follow the patient and write notes when ongoing participation in the clinical care of the patient is warranted. The fellow will also work with the palliative care nurse practitioner who participates on the inpatient team to integrate aspects of palliative care into the patient’s treatment plan as appropriate.
Fellows will have one-half day per week general hematology/oncology continuity clinic for the duration of their training. They will also participate in subspecialty clinic experiences in breast cancer, hematology, and gastroenterology/genetics. Outpatient care electives include lab medicine/blood bank, GYN oncology, pediatric hematology/oncology, radiation oncology and palliative care.
Stem Cell Transplant/Malignant Hematology
Fellows rotating on the in-patient unit will experience two months rotation at Henry Ford Hospital one month for BMT. Fellows will experience a comprehensive in-depth exposure to the acute management of patients with hematologic and non-hematologic malignancies who are undergoing autologous or allogeneic transplantation, and patients who are undergoing salvage chemotherapy prior to initiation of the transplant maneuver. In addition to one dedicated month for in-patient malignant hematology, will be familiar with the diagnosis and management of hematologic malignancies.
There are multiple research opportunities both within the Department of Hematology and Oncology and within other departments. Fellows will have 12 months during their fellowship that they can devote to research. They will maintain one-half day of continuity clinic, and another one-half day clinic of their choice and focus of interest during their research year, with the majority of their remaining time dedicated to research. The focus of the research project can be clinical, epidemiological, health policy, translational, basic or other areas if it is of significant educational value for research training in hematology and oncology.
We accept applications only through ERAS.